Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank
Corresponding Author
Úna C. Mc Menamin
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Correspondence to: Dr. Úna Mc Menamin, Institute of Clinical Sciences Block B, Queen's University Belfast, Royal Victoria Hospital, Belfast, Northern Ireland BT12 6BA, Tel.: +44 (0) 28 90971606, Fax: +44 (0) 28 90235900, E-mail: [email protected]Search for more papers by this authorAndrew T. Kunzmann
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorMichael B. Cook
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD
Search for more papers by this authorBrian T. Johnston
Department of Gastroenterology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, Northern Ireland
Search for more papers by this authorLiam J. Murray
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Centre of Excellence for Public Health (NI), Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Deceased.
Search for more papers by this authorAndrew D. Spence
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorMarie M. Cantwell
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorChris R. Cardwell
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorCorresponding Author
Úna C. Mc Menamin
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Correspondence to: Dr. Úna Mc Menamin, Institute of Clinical Sciences Block B, Queen's University Belfast, Royal Victoria Hospital, Belfast, Northern Ireland BT12 6BA, Tel.: +44 (0) 28 90971606, Fax: +44 (0) 28 90235900, E-mail: [email protected]Search for more papers by this authorAndrew T. Kunzmann
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorMichael B. Cook
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD
Search for more papers by this authorBrian T. Johnston
Department of Gastroenterology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, Northern Ireland
Search for more papers by this authorLiam J. Murray
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Centre of Excellence for Public Health (NI), Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Deceased.
Search for more papers by this authorAndrew D. Spence
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorMarie M. Cantwell
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorChris R. Cardwell
Cancer Epidemiology Research Group, Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland
Search for more papers by this authorAbstract
Incidence of upper gastrointestinal cancers of the oesophagus and stomach show a strong unexplained male predominance. Hormonal and reproductive factors have been associated with upper gastrointestinal cancers in women but there is little available data on men. To investigate this, we included 219,425 men enrolled in the UK Biobank in 2006–2010. Baseline assessments provided information on hormonal and reproductive factors (specifically hair baldness, number of children fathered, relative age at first facial hair and relative age voice broke) and incident oesophageal or gastric cancers were identified through linkage to U.K. cancer registries. Unadjusted and adjusted hazard ratios (HR) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models. During 8 years of follow-up, 309 oesophageal 210 gastric cancers occurred. There was some evidence that male pattern baldness, was associated with gastric cancer risk (adjusted HR 1.35, 95% CI 0.97, 1.88), particularly for frontal male pattern baldness (adjusted HR 1.52, 95% CI 1.02, 2.28). There was little evidence of association between other hormonal and reproductive factors and risk of oesophageal or gastric cancer, overall or by histological subtype. In the first study of a range of male hormonal and reproductive factors and gastric cancer, there was a suggestion that male pattern baldness, often used as a proxy of sex hormone levels, may be associated with gastric cancer. Future prospective studies that directly test circulating sex steroid hormone levels in relation to upper gastrointestinal cancer risk are warranted.
Abstract
What's new?
Esophageal and gastric cancers occur more frequently in men than women. While these malignancies have been associated with hormonal and reproductive factors in women, whether such associations also exist in men is unclear. The authors of the present study investigated potential links between upper gastrointestinal cancer risk and male hormonal and reproductive factors in men enrolled in the UK Biobank prospective study. Only male pattern baldness was associated with gastric cancer risk. The relationship was strongest for frontal male pattern baldness. The findings warrant further investigation for possible relationships between hormone levels and upper gastrointestinal cancer risk.
References
- 1 Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics. CA Cancer J Clin. 2015; 65: 87–108.
- 2 Cancer Research UK. Oesophageal Cancer Survival Statistics. London: Cancer Research UK. Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/oesophageal-cancer/survival. [Accessed May 2017].
- 3 Cancer Research UK. Stomach Cancer Survival Statistics. London: Cancer Research UK. Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/stomach-cancer/survival. [Accessed May 2017].
- 4 Office for National Statistics. Cancer Incidence and Mortality in the United Kingdom, 2008-10. England: Statistical Bulletin, 2012.
- 5 Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013; 63: 232–48.
- 6 Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008; 44: 2397–403.
- 7 Coupland VH, Allum W, Blazeby JM, et al. Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer. 2012; 12: 11.
- 8 Colquhoun A, Arnold M, Ferlay J, et al. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015; 64: 1881–8.
- 9
Tutton PJM,
Barkla DH. The influence of androgens, anti-androgens, and castration on cell proliferation in the jejunal and colonic crypt epithelia, and in dimethylhydrazine-induced adenocarcinoma of rat colon. Virchows Archiv B Cell Pathol. 1981; 38: 351–5.
10.1007/BF02892830 Google Scholar
- 10 Maasberg M, Rotsch M, Jaques G, et al. Androgen receptors, androgen-dependent proliferation, and 5 alpha-reductase activity of small-cell lung cancer cell lines. Int J Cancer. 1989; 43: 685–91.
- 11 Ørsted DD, Nordestgaard BG, Bojesen SE. Plasma testosterone in the general population, cancer prognosis and cancer risk: a prospective cohort study. Ann Oncol. 2014; 25: 712–8.
- 12 Furukawa H, Iwanaga T, Koyama H, et al. Effect of sex hormones on carcinogenesis in the stomachs of rats. Cancer Res. 1982; 42: 5181–2.
- 13 Dong H, Xu J, Li W, et al. Reciprocal androgen receptor/interleukin-6 crosstalk drives oesophageal carcinoma progression and contributes to patient prognosis. J Pathol. 2017; 241: 448–62.
- 14 Jukic Z, Radulovic P, Stojković R, et al. Gender difference in distribution of estrogen and androgen receptors in intestinal-type gastric cancer. Anticancer Res. 2017; 37: 197–202.
- 15 Rashid F, Khan RN, Iftikhar SY. Probing the link between oestrogen receptors and oesophageal cancer. World J Surg Oncol. 2010; 8: 9.
- 16 Gan L, He J, Zhang X, et al. Expression profile and prognostic role of sex hormone receptors in gastric cancer. BMC Cancer. 2012; 12: 1.
- 17 Awan AK, Iftikhar SY, Morris TM, et al. Androgen receptors may act in a paracrine manner to regulate oesophageal adenocarcinoma growth. Eur J Surg Oncol. 2007; 33: 561–8.
- 18 Kominea A, Konstantinopoulos PA, Kapranos N, et al. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer. J Cancer Res Clin Oncol. 2004; 130: 253–8.
- 19 Sukocheva OA, Li B, Due SL, et al. Androgens and esophageal cancer: what do we know?. World J Gastroenterol. 2015; 21: 6146–56.
- 20 Zhang B, Du T, Zang M, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 2014; 5: 10584–95.
- 21 Cooper SC, Croft S, Day R, et al. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma? Cancer Causes Control. 2009; 20: 1363–8.
- 22 Cooper SC, Trudgill NJ. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database. Cancer Causes Control. 2012; 23: 819–25.
- 23 Lu Y, Lagergren J. Reproductive factors and risk of oesophageal cancer, a population-based nested case–control study in Sweden. Br J Cancer. 2012; 107: 564–9.
- 24 Allen N, Sudlow C, Downey P, et al. UK Biobank: current status and what it means for epidemiology. Heal Policy Technol. 2012; 1: 123–6.
- 25 Townsend P. Deprivation. J Soc Pol. 1987; 16: 125–46.
- 26 International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels, Belgium: International Diabetes Federation, 2006.
- 27 Zhou CK, Levine PH, Cleary SD, et al. Male pattern baldness in relation to prostate cancer – specific mortality: a prospective analysis in the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 2016; 183: 210–7.
- 28 Zhou CK, Littman AJ, Levine PH, et al. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins And Lifestyle (VITAL) cohort study. Prostate. 2015; 75: 415–23.
- 29 Keum N, Cao Y, Lee DH, et al. Male pattern baldness and risk of colorectal neoplasia. Br J Cancer. 2016; 114: 110–7.
- 30 Jasienska G, Jasienski M, Ellison PT. Testosterone levels correlate with the number of children in human males, but the direction of the relationship depends on paternal education. Evol Hum Behav. 2012; 33: 665–71.
- 31 Wang BJ, Zhang B, Yan SS, et al. Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis. Dis Esophagus. 2016; 29: 448–54.
- 32 Cronin-Fenton DP, Murray LJ, Whiteman DC, et al. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010; 46: 2067–76.
- 33 Camargo MC, Goto Y, Zabaleta J, et al. Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012; 21: 20–38.
- 34 Lagergren K, Lagergren J, Brusselaers N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis. Int J Cancer. 2014; 135: 2183–90.
- 35 Ellis JA, Sinclair RD. Male pattern baldness: current treatments, future prospects. Drug Discov Today. 2008; 13: 791–7.
- 36 Bang HJ, Yang YJ, Lho DS, et al. Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness. J Dermatol Sci. 2004; 34: 11–6.
- 37 Sanke S, Chander R, Jain A, et al. A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women. JAMA Dermatol. 2016; 152: 986–91.
- 38 Cipriani R, Ruzza G, Foresta C, et al. Sex hormone-binding globulin and saliva testosterone levels in men with androgenetic alopecia. Br J Dermatol. 1983; 109: 249–52.
- 39 Petrick JL, Falk RT, Hyland PL, et al. Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR study. PLoS One. 2018; 13:e0190325
- 40 Cook MB, Wood SN, Cash BD, et al. Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis. Clin Gastroenterol Hepatol. 2015; 13: 673–82.
- 41 Cook MB, Wood S, Hyland PL, et al. Sex steroid hormones in relation to Barrett's esophagus: an analysis of the FINBAR Study. Andrology. 2017; 5: 240–7.
- 42 Steffen A, Huerta JM, Weiderpass E, et al. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2015; 137: 646–57.
- 43 Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut. 2008; 57: 173–80.
- 44 Eriksson J, Haring R, Grarup N, et al. Causal relationship between obesity and serum testosterone status in men: a bi-directional mendelian randomization analysis. PLoS One. 2017; 12:e0176277.
- 45 Simpson E, Rubin G, Clyne C, et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab. 2000; 11: 184–8.
- 46 Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997; 29: 95–120.
- 47 Key TJ, Allen NE, Spencer EA, et al. The effect of diet on risk of cancer. Lancet. 2002; 360: 861–8.
- 48 Holmes MD, Spiegelman D, Willett WC, et al. Dietary fat intake and endogenous sex steroid hormone levels in postmenopausal women. JCO. 2000; 18: 3668–76.
- 49 Allen NE, Key TJ. The effects of diet on circulating sex hormone levels in men. Nutr Res Rev. 2000; 13: 159–84.
- 50 Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual history and menarcheal body size: after 30 years, how well do women remember? Am J Epidemiol. 2002; 155: 672–9.
- 51 Taylor R, Matassa J, Leavy JE, et al. Validity of self reported male baldness patterns in epidemiological studies. BMC Public Health. 2004; 4: 60.
- 52 Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with the general population. Am J Epidemiol. 2017; 186: 1026–34.
- 53 Cook MB, Wild CP, Forman D. A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol. 2005; 162: 1050–61.
- 54 Cook MB, Corley DA, Murray LJ, et al. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One. 2014; 9:e103508.
- 55 Chen J, Bu XL, Wang QY, et al. Decreasing seroprevalence of Helicobacter pylori infection during 1993–2003 in Guangzhou, southern China. Helicobacter. 2007; 12: 164–9.
- 56 Malaty HM, El-Kasabany A, Graham DY, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002; 359: 931–5.
- 57 Duell EJ, Travier N, Leila LB, et al. Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the european prospective investigation into cancer and nutrition. Am J Epidemiol. 2010; 172: 1384–93.
- 58 Freedman ND, Chow W-H, Gao Y-T, et al. Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut. 2007; 56: 1671–7.
- 59 Spechler SJ. Barrett esophagus and risk of esophageal cancer. JAMA. 2013; 310: 627–36.